Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE HealthCare
GEHC
|
+$484M |
| 2 |
Microsoft
MSFT
|
+$417M |
| 3 |
Amazon
AMZN
|
+$365M |
| 4 |
Apple
AAPL
|
+$357M |
| 5 |
Merck
MRK
|
+$311M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$420M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$288M |
| 3 |
Philip Morris
PM
|
+$246M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$228M |
| 5 |
Meta Platforms (Facebook)
META
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.14% |
| 2 | Healthcare | 13.96% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Atea Pharmaceuticals
AVIR
$413M
| $4.99M | ﹤0.01% |
1,490,064
+52,705
| +4% | +$214K |
|
2627
Kodak
KODK
$966M
| $4.99M | ﹤0.01% |
1,216,883
+32,255
| +3% | +$116K |
|
2628
Hyliion Holdings
HYLN
$695M
| $4.97M | ﹤0.01% |
2,508,188
+119,607
| +5% | +$333K |
|
2629
GoodRx Holdings
GDRX
$1.27B
| $4.94M | ﹤0.01% |
790,604
+51,326
| +7% | +$286K |
|
2630
Colliers International
CIGI
$5.12B
| $4.92M | ﹤0.01% |
46,580
-5,040
| -10% | -$540K |
|
|
MCBC
2631
DELISTED
Macatawa Bank Corp
MCBC
| $4.9M | ﹤0.01% |
479,822
+17,823
| +4% | +$189K |
|
2632
Unisys
UIS
$214M
| $4.89M | ﹤0.01% |
1,261,452
+67,555
| +6% | +$326K |
|
2633
Butterfly Network
BFLY
$2.31B
| $4.88M | ﹤0.01% |
2,596,888
+19,921
| +0.8% | +$46.5K |
|
2634
Sutro Biopharma
STRO
$420M
| $4.88M | ﹤0.01% |
105,631
+3,523
| +3% | +$224K |
|
2635
Evolv Technologies
EVLV
$1.1B
| $4.86M | ﹤0.01% |
1,556,279
+65,190
| +4% | +$186K |
|
2636
Alerus Financial
ALRS
$830M
| $4.85M | ﹤0.01% |
302,259
+11,687
| +4% | +$232K |
|
2637
Aldeyra Therapeutics
ALDX
$94.1M
| $4.85M | ﹤0.01% |
488,345
+21,768
| +5% | +$154K |
|
|
BVH
2638
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $4.83M | ﹤0.01% |
176,342
-29,249
| -14% | -$871K |
|
|
SCPL
2639
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $4.81M | ﹤0.01% |
283,322
-5,540
| -2% | -$90.9K |
|
|
PARAA
2640
DELISTED
Paramount Global Class A
PARAA
| $4.8M | ﹤0.01% |
185,931
+22,125
| +14% | +$548K |
|
2641
SIGA Technologies
SIGA
$221M
| $4.8M | ﹤0.01% |
834,570
+31,859
| +4% | +$213K |
|
2642
John Marshall Bancorp
JMSB
$326M
| $4.78M | ﹤0.01% |
221,306
+9,012
| +4% | +$224K |
|
2643
Civista Bancshares
CIVB
$591M
| $4.78M | ﹤0.01% |
283,094
+2,929
| +1% | +$60.8K |
|
2644
Douglas Elliman
DOUG
$159M
| $4.77M | ﹤0.01% |
1,611,712
+35,520
| +2% | +$142K |
|
|
HLVX
2645
DELISTED
HilleVax
HLVX
| $4.75M | ﹤0.01% |
287,276
+9,470
| +3% | +$152K |
|
2646
eHealth
EHTH
$43.9M
| $4.75M | ﹤0.01% |
507,080
+37,561
| +8% | +$295K |
|
|
WW
2647
DELISTED
WW International
WW
| $4.74M | ﹤0.01% |
1,151,622
-10,752
| -0.9% | -$47K |
|
2648
OptimizeRx
OPRX
$133M
| $4.73M | ﹤0.01% |
323,590
+8,030
| +3% | +$134K |
|
2649
Shore Bancshares
SHBI
$796M
| $4.73M | ﹤0.01% |
331,389
+11,973
| +4% | +$199K |
|
|
BBUC
2650
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.07B
| $4.72M | ﹤0.01% |
238,368
+13,557
| +6% | +$271K |
|
Similar funds
Geode Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Geode Capital Management held 4,968 positions worth $770B, up 8.1% from $713B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 4.6%. Geode Capital Management opened 69 new positions and exited 162, leaving the 4,968-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q1 2023 buy was GE HealthCare: 6,775,612 shares worth $554M.
- Geode Capital Management added most to Microsoft in Q1 2023, an estimated $417M increase.
- Geode Capital Management's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $420M.
- Geode Capital Management fully exited SVB Financial Group in Q1 2023, selling an estimated $288M.
- Geode Capital Management's ten largest holdings make up 23% of its $770B portfolio in Q1 2023.
- Geode Capital Management opened 69 new positions and closed 162 in Q1 2023.
- Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $770B.
Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.